[PR Newswire] - PRINCETON, N.J., Feb. 26, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today its financial results for the year ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment